Literature DB >> 19625656

A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.

Daniel Ricklin1, Apostolia Tzekou, Brandon L Garcia, Michal Hammel, William J McWhorter, Georgia Sfyroera, You-Qiang Wu, V Michael Holers, Andrew P Herbert, Paul N Barlow, Brian V Geisbrecht, John D Lambris.   

Abstract

Staphylococcus aureus possesses an impressive arsenal of complement evasion proteins that help the bacterium escape attack of the immune system. The staphylococcal complement inhibitor (SCIN) protein exhibits a particularly high potency and was previously shown to block complement by acting at the level of the C3 convertases. However, many details about the exact binding and inhibitory mechanism remained unclear. In this study, we demonstrate that SCIN directly binds with nanomolar affinity to a functionally important area of C3b that lies near the C terminus of its beta-chain. Direct competition of SCIN with factor B for C3b slightly decreased the formation of surface-bound convertase. However, the main inhibitory effect can be attributed to an entrapment of the assembled convertase in an inactive state. Whereas native C3 is still able to bind to the blocked convertase, no generation and deposition of C3b could be detected in the presence of SCIN. Furthermore, SCIN strongly competes with the binding of factor H to C3b and influences its regulatory activities: the SCIN-stabilized convertase was essentially insensitive to decay acceleration by factor H and the factor I- and H-mediated conversion of surface-bound C3b to iC3b was significantly reduced. By targeting a key area on C3b, SCIN is able to block several essential functions within the alternative pathway, which explains the high potency of the inhibitor. Our findings provide an important insight into complement evasion strategies by S. aureus and may act as a base for further functional studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625656      PMCID: PMC2881335          DOI: 10.4049/jimmunol.0901443

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Structural transitions of complement component C3 and its activation products.

Authors:  Noritaka Nishida; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

2.  A structural basis for complement inhibition by Staphylococcus aureus.

Authors:  Michal Hammel; Georgia Sfyroera; Daniel Ricklin; Paola Magotti; John D Lambris; Brian V Geisbrecht
Journal:  Nat Immunol       Date:  2007-03-11       Impact factor: 25.606

Review 3.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

Review 4.  Exploring the complement interaction network using surface plasmon resonance.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 5.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

6.  Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition.

Authors:  Bert J C Janssen; Els F Halff; John D Lambris; Piet Gros
Journal:  J Biol Chem       Date:  2007-08-06       Impact factor: 5.157

7.  Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus.

Authors:  Julia D Burman; Elisa Leung; Karen L Atkins; Maghnus N O'Seaghdha; Lea Lango; Pau Bernadó; Stefan Bagby; Dmitri I Svergun; Timothy J Foster; David E Isenman; Jean M H van den Elsen
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

Review 8.  The anti-inflammatory activities of Staphylococcus aureus.

Authors:  Triantafyllos Chavakis; Klaus T Preissner; Mathias Herrmann
Journal:  Trends Immunol       Date:  2007-08-02       Impact factor: 16.687

9.  Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus.

Authors:  Michal Hammel; Georgia Sfyroera; Serapion Pyrpassopoulos; Daniel Ricklin; Kasra X Ramyar; Mihai Pop; Zhongmin Jin; John D Lambris; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

10.  Staphylococcal complement evasion by various convertase-blocking molecules.

Authors:  Ilse Jongerius; Jörg Köhl; Manoj K Pandey; Maartje Ruyken; Kok P M van Kessel; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  38 in total

Review 1.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

2.  Inhibiting alternative pathway complement activation by targeting the factor D exosite.

Authors:  Kenneth J Katschke; Ping Wu; Rajkumar Ganesan; Robert F Kelley; Mary A Mathieu; Philip E Hass; Jeremy Murray; Daniel Kirchhofer; Christian Wiesmann; Menno van Lookeren Campagne
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

3.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

4.  Allosteric inhibition of complement function by a staphylococcal immune evasion protein.

Authors:  Hui Chen; Daniel Ricklin; Michal Hammel; Brandon L Garcia; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; Apostolia Tzekou; Sheng Li; Brian V Geisbrecht; Virgil L Woods; John D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

5.  FACIN, a Double-Edged Sword of the Emerging Periodontal Pathogen Filifactor alocis: A Metabolic Enzyme Moonlighting as a Complement Inhibitor.

Authors:  Monika Jusko; Beata Miedziak; David Ermert; Michal Magda; Ben C King; Ewa Bielecka; Kristian Riesbeck; Sigrun Eick; Jan Potempa; Anna M Blom
Journal:  J Immunol       Date:  2016-09-16       Impact factor: 5.422

6.  Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B.

Authors:  Xin Xu; Chi Zhang; Dalton T Denton; Daniel O'Connell; Daniel W Drolet; Brian V Geisbrecht
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

Review 7.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

8.  Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.

Authors:  Chunfang Gu; Sarah A Jenkins; Qiong Xue; Yi Xu
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

Review 9.  Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Authors:  Brandon L Garcia; Kasra X Ramyar; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 10.  Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.

Authors:  Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.